Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783168086> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2783168086 abstract "The IDF estimates that the number of individuals with diabetes will rise by almost 55% to 640 million by 2040. According to the ADA, 86 million Americans aged 20 years and over are prediabetic. We have developed an innovative botanical complex (BC) that aims to reverse prediabetes and to prevent each dysfunction and/or its consequences independently. The ability of the BC to control fasting glycemia, HbA1c, insulin sensitivity, serum and hepatic triglycerides, and weight gain through a specific effect on fat mass has been demonstrated in different animal models (db/db, C57BL/6 high fat diet, C57BL/6NR and Syrian hamster normal diet). Following these results, a first Phase I open trial was initiated on slightly overweight male volunteers (NCT02790489). The study included an initial period of supplementation with 2.5g/ day of the BC for 4 weeks (V1; V2:V1+4weeks) followed by an intermediary analysis and a wash-out period of 2 weeks, then 4 weeks of supplementation with 5.0g/day (V3, V2+2weeks; V4:V3+4weeks). Different safety parameters, in particular hepatic, urinary, renal and hemodynamic, were assessed at all visits. Glycemia and insulinemia were also monitored from catheter samples after taking a standardized breakfast (Breakfast Tolerance Test: BTT) at V3 and V4. Fourteen volunteers completed the trial; 1 volunteer left the study after V2 due to a persistent health problem identified on inclusion that was independent of the BC. The results do not show any clinically significant increase in the various safety parameters, objectifying the very good tolerance of the BC for the two doses tested. In addition, BC did not induce an increase in insulin secretion during the BTT. Conversely, we observed a decrease in the insulinemia AUC (V4:3286±624 versus V3:5445±1240mUI.min/L,-40%, p=0.02), and a downward trend for the glycemia AUC (V4:118±28 versus V3:168±28mmol.min/L,-30%, p=0.08). The candidate BC is currently undergoing a Phase 2a trial on 80 prediabetic subjects with abdominal obesity (NCT02868177)." @default.
- W2783168086 created "2018-01-26" @default.
- W2783168086 creator A5011534443 @default.
- W2783168086 creator A5012135591 @default.
- W2783168086 creator A5033397745 @default.
- W2783168086 creator A5036480804 @default.
- W2783168086 creator A5042259706 @default.
- W2783168086 creator A5044069348 @default.
- W2783168086 creator A5057167033 @default.
- W2783168086 creator A5072472816 @default.
- W2783168086 creator A5087185601 @default.
- W2783168086 creator A5089516264 @default.
- W2783168086 date "2017-06-09" @default.
- W2783168086 modified "2023-09-24" @default.
- W2783168086 title "Phase I clinical trial to evaluate TOTUM-63, a botanical complex for managing prediabetes" @default.
- W2783168086 hasPublicationYear "2017" @default.
- W2783168086 type Work @default.
- W2783168086 sameAs 2783168086 @default.
- W2783168086 citedByCount "0" @default.
- W2783168086 crossrefType "proceedings-article" @default.
- W2783168086 hasAuthorship W2783168086A5011534443 @default.
- W2783168086 hasAuthorship W2783168086A5012135591 @default.
- W2783168086 hasAuthorship W2783168086A5033397745 @default.
- W2783168086 hasAuthorship W2783168086A5036480804 @default.
- W2783168086 hasAuthorship W2783168086A5042259706 @default.
- W2783168086 hasAuthorship W2783168086A5044069348 @default.
- W2783168086 hasAuthorship W2783168086A5057167033 @default.
- W2783168086 hasAuthorship W2783168086A5072472816 @default.
- W2783168086 hasAuthorship W2783168086A5087185601 @default.
- W2783168086 hasAuthorship W2783168086A5089516264 @default.
- W2783168086 hasBestOaLocation W27831680861 @default.
- W2783168086 hasConcept C126322002 @default.
- W2783168086 hasConcept C134018914 @default.
- W2783168086 hasConcept C2777180221 @default.
- W2783168086 hasConcept C2779668308 @default.
- W2783168086 hasConcept C41008148 @default.
- W2783168086 hasConcept C535046627 @default.
- W2783168086 hasConcept C555293320 @default.
- W2783168086 hasConcept C71924100 @default.
- W2783168086 hasConceptScore W2783168086C126322002 @default.
- W2783168086 hasConceptScore W2783168086C134018914 @default.
- W2783168086 hasConceptScore W2783168086C2777180221 @default.
- W2783168086 hasConceptScore W2783168086C2779668308 @default.
- W2783168086 hasConceptScore W2783168086C41008148 @default.
- W2783168086 hasConceptScore W2783168086C535046627 @default.
- W2783168086 hasConceptScore W2783168086C555293320 @default.
- W2783168086 hasConceptScore W2783168086C71924100 @default.
- W2783168086 hasLocation W27831680861 @default.
- W2783168086 hasLocation W27831680862 @default.
- W2783168086 hasOpenAccess W2783168086 @default.
- W2783168086 hasPrimaryLocation W27831680861 @default.
- W2783168086 hasRelatedWork W2062898667 @default.
- W2783168086 hasRelatedWork W2116128857 @default.
- W2783168086 hasRelatedWork W2285022769 @default.
- W2783168086 hasRelatedWork W2414156024 @default.
- W2783168086 hasRelatedWork W2748952813 @default.
- W2783168086 hasRelatedWork W2899084033 @default.
- W2783168086 hasRelatedWork W2945745351 @default.
- W2783168086 hasRelatedWork W3031052312 @default.
- W2783168086 hasRelatedWork W3112431429 @default.
- W2783168086 hasRelatedWork W4321115625 @default.
- W2783168086 isParatext "false" @default.
- W2783168086 isRetracted "false" @default.
- W2783168086 magId "2783168086" @default.
- W2783168086 workType "article" @default.